title: JAK2 V617F mutation is not involved in thromboembolism in IBD.
authors.forename: Ouafae
authors.initials: O
authors.lastname: Karimi
authors.forename: J Bart A
authors.initials: JB
authors.lastname: Crusius
authors.forename: Constantina
authors.initials: C
authors.lastname: Coucoutsi
authors.forename: Roel
authors.initials: R
authors.lastname: Heijmans
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Sambuelli
authors.forename: A Salvador
authors.initials: AS
authors.lastname: Peña
authors.forename: Ioannis E
authors.initials: IE
authors.lastname: Koutroubakis
mesh_terms: D000293:Adolescent; D000328:Adult; D001118:Argentina / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D003093:Colitis, Ulcerative / Q000453:epidemiology / Q000235:genetics; D003424:Crohn Disease / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000453:epidemiology / Q000235:genetics*; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013923:Thromboembolism / Q000453:epidemiology / Q000235:genetics*; D055815:Young Adult
chemical_list: D053614:Janus Kinase 2